InvestorsHub Logo
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Thursday, 12/08/2016 7:43:50 PM

Thursday, December 08, 2016 7:43:50 PM

Post# of 209
MYL obtains IPRs on several Restatis patents:

http://finance.yahoo.com/news/allergan-comments-ptab-decision-regarding-203900309.html

Restasis is AGN’s second-largest drug (after Botox).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”